Sequential Changes in Serum Triglyceride Levels During Adjuvant Tamoxifen Therapy in Breast Cancer Patients and the Effect of Dose Reduction

By Liu C-L.   Yang T-L.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 1, 2003-05 ,pp. : 11-16

Springer Publishing Company

Access to resources Recommend Favorite

Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials

By Zhou Wen-Bin  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 625-631

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden

By Lundkvist Jonas   Wilking Nils   Holmberg Stig   Jönsson Linus  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 289-299

Springer Publishing Company

Access to resources Recommend Favorite

Estrogenic Effects of Toremifene and Tamoxifen in Postmenopausal Breast Cancer Patients

By Ellmén J.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-01 ,pp. : 103-111

Springer Publishing Company

Access to resources Recommend Favorite

Comparison between the Effects of Tamoxifen and Toremifene on the Uterus in Postmenopausal Breast Cancer Patients

By TOMÁS E.   Kauppila A.   Blanco G.   Apaja-Sarkkinen M.   Laatikainen T.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 261-266

Academic Press

Access to resources Recommend Favorite